Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01286181 · ClinicalTrials.gov registry record · NA

Device-guided Breathing for Shortness of Breath in COPD

A NA study of COPD and Dyspnea, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
11
Enrollment target
1
Study location

NCT01286181 is a NA study of COPD and Dyspnea that has completed, run by Mayo Clinic. The registered enrollment target is 11 participants, below the 2,418-participant average among 85 other COPD trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01286181, a NA study of COPD and Dyspnea, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
11 participants
Enrollment target
1
Study location

Study Summary

Although drug therapies and pulmonary rehabilitation have greatly improved COPD symptoms, as many as 50% of patients with severe COPD have inadequately controlled dyspnea. Device-guided breathing is a behavioral intervention that guides respiratory rates into a therapeutic range; prolongation of the expiratory phase improves hyperinflation, the most significant driver of dyspnea in this population. Device-guided breathing, has no known side-effects, and may represent a cost effective adjunctive treatment for dyspnea in severe COPD.

Interventions

  • BEHAVIORAL Twice daily practice of device-guided slow breathing.

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2011-01
Est. Completion 2011-12
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT01286181

The ClinicalTrials.gov registry entry for NCT01286181 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,418-participant average among 85 other COPD trials with a reported enrollment target (100% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with COPD appearing as the primary indexed condition, and to 1 intervention - of which Twice daily practice of device-guided slow breathing. is the first listed.

NCT01286181 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT01286181 about?

NCT01286181 is a clinical study titled "Device-guided Breathing for Shortness of Breath in COPD". Although drug therapies and pulmonary rehabilitation have greatly improved COPD symptoms, as many as 50% of patients with severe COPD have inadequately controlled dyspnea. Device-guided breathing is a behavioral intervention that guides respiratory rates into a therapeutic range; prolongation of the...

What is the current status of trial NCT01286181?

This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2011-01. Estimated completion is 2011-12.

What conditions does trial NCT01286181 study?

This clinical trial studies the following conditions: COPD, Dyspnea, Hyperinflation.

What interventions are being tested in trial NCT01286181?

The interventions under investigation include: Twice daily practice of device-guided slow breathing. (BEHAVIORAL).

Who is sponsoring clinical trial NCT01286181?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01286181 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COPD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.